Skip to content
Open access

Liraglutide in Adults With Obesity: A Multicentre, Single‐Arm, Post‐Marketing Surveillance Study in Taiwan

Sep 2026 · Endocrinology, Diabetes & Metabolism · Vol 9 · 1 citation · 39 references
Medicine

Abstract

This prospective study (NCT06283641) was the first real‐world, multicentre, post‐marketing surveillance of GLP‐1 receptor agonist liraglutide as an adjunct for weight management in adults with obesity in Taiwan.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.